| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |